PA
VYGR icon

Perceptive Advisors’s Voyager Therapeutics VYGR Stock Holding History

Perceptive Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-36,573
Closed -$996K – 125
2019
Q2 		$996K Buy
+36,573
New +$837K 0.02% 90
2017
Q4 		– Sell
-34,604
Closed -$712K – 154
2017
Q3 		$712K Hold
34,604
– – 0.03% 108
2017
Q2 		$310K Buy
+34,604
New +$348K 0.02% 119
2016
Q3 		– Sell
-650
Closed -$7K – 217
2016
Q2 		$7K Buy
+650
New +$7.95K ﹤0.01% 168

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Perceptive Advisors's VYGR Position: Q3 2019 in Review

Perceptive Advisors sold out of Voyager Therapeutics (VYGR) in Q3 2019, closing a stake of 36,573 shares — an estimated $996K sold.

Perceptive Advisors first reported a position in VYGR in Q2 2016 and held it in 4 quarters. The position peaked at $996K in Q2 2019. 131 funds tracked by Wall St. Rank hold VYGR as of Q3 2019.

  • Perceptive Advisors reported no remaining Voyager Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Perceptive Advisors sold 36,573 Voyager Therapeutics shares in Q3 2019, an estimated $996K.
  • Perceptive Advisors first reported a position in Voyager Therapeutics in Q2 2016 and held it in 4 quarters.
  • Perceptive Advisors's Voyager Therapeutics position peaked at $996K in Q2 2019.
  • 131 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2019.

Based on Perceptive Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.